Ferring Pharmaceuticals Inc recalls Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal ap
Recalled July 5, 2023 · FDA recall D-0879-2023 · Ferring Pharmaceuticals
Hazard
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products · FDA Class II
Units
N/A
Sold at
USA Nationwide
Description
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Product
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03
Manufacturer(s)
Ferring Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →